[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ

Nature volume 437, pages 759–763 (2005)Cite this article

Abstract

Peroxisome proliferator-activated receptor-γ (PPAR-γ) has essential roles in adipogenesis and glucose homeostasis, and is a molecular target of insulin-sensitizing drugs1,2,3. Although the ability of PPAR-γ agonists to antagonize inflammatory responses by transrepression of nuclear factor kappa B (NF-κB) target genes is linked to antidiabetic4 and antiatherogenic actions5, the mechanisms remain poorly understood. Here we report the identification of a molecular pathway by which PPAR-γ represses the transcriptional activation of inflammatory response genes in mouse macrophages. The initial step of this pathway involves ligand-dependent SUMOylation of the PPAR-γ ligand-binding domain, which targets PPAR-γ to nuclear receptor corepressor (NCoR)–histone deacetylase-3 (HDAC3) complexes on inflammatory gene promoters. This in turn prevents recruitment of the ubiquitylation/19S proteosome machinery that normally mediates the signal-dependent removal of corepressor complexes required for gene activation. As a result, NCoR complexes are not cleared from the promoter and target genes are maintained in a repressed state. This mechanism provides an explanation for how an agonist-bound nuclear receptor can be converted from an activator of transcription to a promoter-specific repressor of NF-κB target genes that regulate immunity and homeostasis.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: PPAR-γ prevents LPS-induced dissociation of the NCoR–HDAC3 complex from the iNOS promoter.
Figure 2: PIAS1 interacts with PPAR-γ and is required for transrepression of iNOS.
Figure 3: Ligand-dependent SUMOylation of PPAR-γ is required for transrepression.
Figure 4: SUMOylation of PPAR-γ promotes interaction with the NCoR–HDAC3 complex.

Similar content being viewed by others

References

  1. Lehmann, J. M. et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J. Biol. Chem. 270, 12953–12956 (1995)

    Article  CAS  Google Scholar 

  2. Spiegelman, B. M. PPARγ: adipogenic regulator and thiazolidinedione receptor. Diabetes 47, 507–514 (1998)

    Article  CAS  Google Scholar 

  3. Willson, T. M., Lambert, M. H. & Kliewer, S. A. Peroxisome proliferator-activated receptor γ and metabolic disease. Annu. Rev. Biochem. 70, 341–367 (2001)

    Article  CAS  Google Scholar 

  4. Haffner, S. M. et al. Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus. Circulation 106, 679–684 (2002)

    Article  CAS  Google Scholar 

  5. Li, A. et al. Peroxisome proliferator-activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J. CIin. Invest. 106, 523–531 (2000)

    Article  CAS  Google Scholar 

  6. Chen, J. D. & Evans, R. M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377, 454–457 (1995)

    Article  ADS  CAS  Google Scholar 

  7. Horlein, A. J. et al. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377, 397–404 (1995)

    Article  ADS  CAS  Google Scholar 

  8. Glass, C. K. & Rosenfeld, M. G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14, 121–141 (2000)

    CAS  Google Scholar 

  9. Guenther, M., Lane, W., Fischle, W., Verdin, E. & Lazar, M. A Core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness. Genes Dev. 14, 1048–1057 (2000)

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Li, J. et al. Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J. 19, 4342–4350 (2000)

    Article  CAS  Google Scholar 

  11. Zhang, J., Kalkum, M., Chait, B. T. & Roeder, R. G. The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2. Mol. Cell 9, 611–623 (2002)

    Article  CAS  Google Scholar 

  12. Yoon, H. G. et al. Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1. EMBO J. 22, 1336–1346 (2003)

    Article  CAS  Google Scholar 

  13. Perissi, V., Aggarwal, A., Glass, C. K., Rose, D. W. & Rosenfeld, M. G. A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 116, 511–526 (2004)

    Article  CAS  Google Scholar 

  14. Ogawa, S. et al. A nuclear receptor corepressor transcriptional checkpoint controlling activator protein 1-dependent gene networks required for macrophage activation. Proc. Natl Acad. Sci. USA 101, 14461–14466 (2004)

    Article  ADS  CAS  Google Scholar 

  15. Hoberg, J. E., Yeung, F. & Mayo, M. W. SMRT derepression by the IκB kinase α: A prerequisite to NF-κB transcription and survival. Mol. Cell 16, 245–255 (2004)

    Article  CAS  Google Scholar 

  16. Lowenstein, C. J. et al. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon γ and lipopolysaccharide. Proc. Natl Acad. Sci. USA 90, 9730–9734 (1993)

    Article  ADS  CAS  Google Scholar 

  17. Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J. & Glass, C. K. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391, 79–82 (1998)

    Article  ADS  CAS  Google Scholar 

  18. Oberfield, J. L. et al. A peroxisome proliferator-activated receptor γ ligand inhibits adipocyte differentiation. Proc. Natl Acad. Sci. USA 96, 6102–6106 (1999)

    Article  ADS  CAS  Google Scholar 

  19. Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomazy, V. A. & Evans, R. M. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93, 241–252 (1998)

    Article  CAS  Google Scholar 

  20. Li, M., Pascual, G. & Glass, C. Peroxisome proliferator-activated receptor γ-dependent repression of the inducible nitric oxide synthase gene. Mol. Cell. Biol. 20, 4699–4707 (2000)

    Article  CAS  Google Scholar 

  21. Liu, B. et al. Inhibition of Stat1-mediated gene activation by PIAS1. Proc. Natl Acad. Sci. USA 95, 10626–10631 (1998)

    Article  ADS  CAS  Google Scholar 

  22. Jackson, P. K. A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases. Genes Dev. 15, 3053–3058 (2001)

    Article  CAS  Google Scholar 

  23. Tallec, L. P. et al. Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification. Mol. Endocrinol. 17, 2529–2542 (2003)

    Article  Google Scholar 

  24. Janne, O. A. et al. Androgen-receptor-interacting nuclear proteins. Biochem. Soc. Trans. 28, 401–405 (2000)

    Article  CAS  Google Scholar 

  25. Tan, J. et al. Protein inhibitor of activated STAT-1 (signal transducer and activator of transcription-1) is a nuclear receptor coregulator expressed in human testis. Mol. Endocrinol. 14, 14–26 (2000)

    Article  CAS  Google Scholar 

  26. Kotaja, N., Karvonen, U., Janne, O. A. & Palvimo, J. J. PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol. Cell. Biol. 22, 5222–5234 (2002)

    Article  CAS  Google Scholar 

  27. Ling, Y. et al. Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription. Nucleic Acids Res. 32, 598–610 (2004)

    Article  CAS  Google Scholar 

  28. Nishida, T. & Yasuda, H. PIAS1 and PIASxα function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription. J. Biol. Chem. 277, 41311–41317 (2002)

    Article  CAS  Google Scholar 

  29. Ohshima, T., Koga, H. & Shimotohno, K. Transcriptional activity of peroxisome proliferator-activated receptor γ Is modulated by SUMO-1 modification. J. Biol. Chem. 279, 29551–29557 (2004)

    Article  CAS  Google Scholar 

  30. Muller, S., Hoege, C., Pyrowolakis, G. & Jentsch, S. SUMO, ubiquitin's mysterious cousin. Nature Rev. Mol. Cell Biol. 2, 202–210 (2001)

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank A. Beas, W. Books and J. Goode for assistance with the yeast two-hybrid screen, and J. Collier for assistance with the mammalian two-hybrid assays. We thank F. Almazan for RAW264.7 cells. We thank M. Ricote for helpful discussions and M. Lambert for assistance with analysis of PPAR-γ crystal structures. We thank A. Howarth for assistance with preparation of the manuscript. These studies were supported by an American Heart Association Predoctoral Fellowship to G.P. and National Institutes of Health grants to D.W.R., M.G.R. and C.K.G, and support from the Stanford Donald W. Reynolds Cardiovascular Center to C.K.G. M.G.R. is supported by the Howard Hughes Medical Institute. Author Contributions G.P., A.L.F., S.O., A.G., A.C.L. and D.W.R. performed experimental work and data analysis. T.M.W., M.G.R. and C.K.G. performed data analysis. C.K.G. was responsible for project planning.

Author information

Authors and Affiliations

  1. Department of Cellular and Molecular Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, California, 92093, USA

    Gabriel Pascual, Amy L. Fong, Sumito Ogawa, Andrew C. Li & Christopher K. Glass

  2. Howard Hughes Medical Institute, University of California San Diego, 9500 Gilman Drive, La Jolla, California, 92093, USA

    Amir Gamliel, Valentina Perissi & Michael G. Rosenfeld

  3. Department of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, California, 92093, USA

    David W. Rose, Michael G. Rosenfeld & Christopher K. Glass

  4. Biomedical Sciences Graduate Program, University of California San Diego, 9500 Gilman Drive, La Jolla, California, 92093, USA

    Gabriel Pascual & Amy L. Fong

  5. GlaxoSmithKline, 5 Moore Drive, PO Box 13398, Research Triangle Park, North Carolina, 27709, USA

    Timothy M. Willson

Authors
  1. Gabriel Pascual
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amy L. Fong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sumito Ogawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Amir Gamliel
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Andrew C. Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Valentina Perissi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. David W. Rose
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Timothy M. Willson
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Michael G. Rosenfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Christopher K. Glass
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christopher K. Glass.

Ethics declarations

Competing interests

T.M.W. is an employee of GlaxoSmithKline.

Supplementary information

Supplementary Figure S1

Efficacy of siRNAs directed against NCoR, HDAC3, HDAC7, PIAS1 and Ubc9. (PDF 112 kb)

Supplementary Figure S2

NCoR and HDAC3 are required for PPARγ-mediated transrepression. (PDF 115 kb)

Supplementary Figure S3

PPARγ transrepression does not require sequence specific DNA binding and can be extended to other LPS-dependent promoters. (PDF 163 kb)

Supplementary Figure S4

PIAS1 interacts with PPARγ and is required for ligand-dependent inhibition of iNOS gene activation. Supplementary Figure S4 was replaced on 03 February 2006. This figure replaces the erroneous posting of Figure 4 from the main text as Supplementary Figure 4. (PDF 534 kb)

Supplementary Figure S5

Sumoylation is required for PPARγ transrepression and enhances ligand dependent association with NCoR. (PDF 132 kb)

Supplementary Figure Legends

Text to accompany the above Supplementary Figures. (DOC 23 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pascual, G., Fong, A., Ogawa, S. et al. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ. Nature 437, 759–763 (2005). https://doi.org/10.1038/nature03988

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature03988

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing